Radiotherapy in pediatric patients with acute lymphocytic leukemia: a 9-year experience

Authors

DOI:

https://doi.org/10.51481/amc.v64i4.1242

Keywords:

Radiotherapy, acute lymphocytic leukemia, pediatric, epidemiology, treatment

Abstract

Aim: To describe the epidemiological and clinical characteristics of patients with acute lymphocytic leukemia, attended at the National Children´s Hospital ""Dr. Carlos Sáenz Herrera"" that received external radiation therapy between January 2009 and December 2017.

Methods: It is an observational, descriptive study. Clinical records of pediatric patients (0-13 years) with acute lymphoblastic leukemia that received external radiotherapy in the study period were retrospectively reviewed. A descriptive statistical analysis of the qualitative and quantitative variables was applied.

Results: 58 patients were studied, 79,3% were males. The mean age was 7,3 years. 84,2% were classified as L1, 84,2% had common B immunophenotype and 56,9% were in the high risk group at diagnosis. The main indication for radiotherapy was relapse (67,7%). About half the patients received radiotherapy to central nervous system and the other half to testicles. The main side effects were cutaneous.

Conclusions: The results obtained were comparable to those seen in literature. Radiotherapy is important in leukemia treatment, particularly in relapse and high risk patients.

Downloads

Download data is not yet available.

References

Erdmann F, Li T, Luta G, Giddings B, Torres G, Steliarova-Foucher E, et al. Incidence of childhood cancer in Costa Rica, 2000-2014: An international perspective. Cancer Epidemiol. 2018; 56:21-30. DOI: 10.1016/j.canep.2018.07.004

Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol. 2021; 71:101662 . DOI:10.1016/j.canep.2019.101662

Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018; 60:4-12. DOI:10.1111/ped.13457

Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet. 2004; 364:2097-2105. DOI:10.1016/S0140-6736(04)17550-8

Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64:83-103. DOI:10.3322/caac.21219

Mirmohammadi P, Ameri M, Shalbaf A. Recognition of acute lymphoblastic leukemia and lymphocytes cell subtypes in microscopic images using random forest classifier. Phys Eng Sci Med. 2021; 44:433-441. DOI:10.1007/s13246-021-00993-5

Peters JM, Ansari MQ. Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Arch Pathol Lab Med. 2011; 135:44-54. DOI:10.5858/2010-0387-RAR.1

Alves GV, Fernandes AL, Freire JM, Paiva A, Vasconcelos RC, Sales VS, et al. Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome. J Clin Lab Anal. 2012; 26:431-440. DOI:10.1002/jcla.21540

Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020; 105:2524-2539. DOI:10.3324/haematol.2020.247031

Carroll WL, Bhojwani D, Min DJ, Raetz E, Relling M, Davies S, et al. Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2003; 2003:102-131. DOI:10.1182/asheducation-2003.1.102

Vrooman LM, Silverman LW. Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances. Curr Hematol Malig Rep. 2016; 11:385-394. DOI:10.1007/s11899-016-0337-y

Lenk L, Alsadeq A, Schewe DM. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data. Cancer Metastasis Rev. 2020; 39:173-187. DOI:10.1007/s10555-020-09848-z

Nguyen HT, Terao MA, Green DM, Pui CH, Inaba H. Testicular involvement of acute lymphoblastic leukemia in children and adolescents: Diagnosis, biology, and management. Cancer. 2021; 127:3067-3081. DOI:10.1002/cncr.33609

Breneman JC, Donaldson SS, Constine L, Merchant TE, Marcus K, Paulino A, et al. The Children´s Oncology Group radiation oncology discipline: 15 years of contributions to the treatment of childhood cancer. Int J Radiat Oncol Biol Phys. 2018; 101:860-874. DOI:10.1016/j.ijrobp.2018.03.002

Hastings C, Chen Y, Devidas M, Ritchey AK, Winick NJ, Carroll WL, et al. Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children´s Oncology Group study AALL02P2. Pediatr Blood Cancer. 2021; 68:e29256. DOI:10.1002/pbc.29256

Mak KS, Lee SW, Balboni TA, Marcus KJ. Clinical outcomes and toxicity following palliative radiotherapy for childhood cancers. Pediatr Blood Cancer. 2017; 65:e26764. DOI:10.1002/pbc.26764

Rao AD, Chen Q, Ermoian RP, Alcorn SR, Figueiredo ML, Chen MJ, et al. Practice patterns of palliative radiation

therapy in pediatric oncology patients in an international pediatric research consortium. Pediatr Blood Cancer. 2017; 64:e26589. DOI:10.1002/pbc.26589

Choong ES, Turner RN, Flatley MJ. Radiotherapy: basic principles and technical advances. Orthop Trauma. 2014; 28:167-171. DOI: 10.1016/j.mporth.2014.04.003

De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AW, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers. 2019; 5:13. DOI:10.1038/s41572-019-0064-5

Selo N, Bölling T, Ernst I, Pape H, Martini C, Rübe C, et al. Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data. Radiother Oncol. 2010; 97:119-126. DOI:10.1016/j.radonc.2010.04.030

Skinner R. Long-term effects of cancer therapy in children - organs, systems and tissues. Pediatr Child Health. 2012; 22:201-206. DOI:10.1016/j.paed.2012.02.009

Thorp N. Basic principles of paediatric radiotherapy. Clin Oncol (R Coll Radiol). 2013; 25:3-10. DOI:10.1016/j.clon.2012.08.006

Trott KR. Special radiobiological features of second cancer risk after particle radiotherapy. Phys Med. 2017; 42:221-227. DOI:10.1016/j.ejmp.2017.05.002

Beijer JG, Teepen JC, Streefkerk N, Heijnen RM, Janssens GO, Kremer LCM, et al. Late toxicity after 3-dimensional external beam radiotherapy among children with cancer: A systematic review. J Pediatr Hematol Oncol. 2022; 44:117-134. DOI:10.1097/MPH.0000000000002445

Palmer JD, Tsang DS, Tinkle CL, Olch AJ, Kremer LC, Ronckers CM, et al. Late effects of radiation therapy in pediatric patients and survivorship. Pediatr Blood Cancer. 2021; 68:e28349. DOI:10.1002/pbc.28349

Hunger SP, Loh ML, Whitlock JA, Winick NJ, Carroll WL, Devidas M, et al. Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013; 60:957-963. DOI:10.1002/pbc.24420

Williams LA, Richardson M, Kehm RD, McLaughlin CC, Mueller BA, Chow EJ, et al. The association between sex and most childhood cancers is not mediated by birthweight. Cancer Epidemiol. 2018; 57:7-12. DOI:10.1016/j.canep.2018.09.002

Acuña-Navas MJ, Rodríguez-Rodríguez C. Radioterapia en la población oncológica pediátrica de Costa Rica: experiencia de 2 años. Acta med costarric. 2021; 63:131-137. DOI: 10.51481/amc.v63i2.1196

Cerdas B, Rodríguez C. Características clínico-epidemiológicas de los pacientes menores de 18 años tratados con acelerador lineal. Acta pediatr costarric. 2014; 23:29-35.

Chen AC, Okcu MF, Dreyer ZE, Kamdar KY, Sonabend RY, Suzawa HS, et al. Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients. Adv Radiat Oncol. 2017; 2:228-234. DOI:10.1016/j.adro.2017.01.010

Moghrabi A, Levy DE, Asselin B, Barr R, Clavell L, Hurwitz C, et al. Results of the Dana-Farber Cancer Institute ALL consortium protocol 95-01 for children with acute lymphoblastic leukemia. Blood. 2007; 109:896-904. DOI:10.1182/blood-2006-06-027714

Locatelli F, Schrappe M, Bernardo ME, Rutella S. How I treat childhood acute lymphoblastic leukemia. Blood. 2012; 120:2807-2816. DOI:10.1182/blood-2012-02-265884

FitzGerald TJ, Aronowitz J, Cicchetti MG, Fisher G, Kadish S, Lo YC, et al. The effect of radiation therapy on normal tissue function. Hematol Oncol Clin Norh Am. 2006; 20:141-163. DOI:10.1016/j.hoc.2006.01.005

Hernández Aragüés I, Pulido Pérez A, Suárez Fernández R. Inflammatory skin conditions associated with radiotherapy. Actas Dermosifiliogr. 2017; 108:209-220. DOI:10.1016/j.ad.2016.09.011

Published

2022-12-31

How to Cite

Radiotherapy in pediatric patients with acute lymphocytic leukemia: a 9-year experience. (2022). Acta Médica Costarricense , 64(4), 1-7. https://doi.org/10.51481/amc.v64i4.1242